RAM
JAZZ icon

Riggs Asset Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Riggs Asset Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-75
Closed -$9K – 273
2016
Q3 		$9K Sell
75
-39,484
-100% -$5.32M ﹤0.01% 198
2016
Q2 		$5.59M Buy
39,559
+233
+0.6% +$34.3K 2.93% 11
2016
Q1 		$5.13M Buy
39,326
+4,507
+13% +$561K 3.69% 13
2015
Q4 		$4.89M Sell
34,819
-22,416
-39% -$3.11M 2.42% 21
2015
Q3 		$7.6M Sell
57,235
-443
-0.8% -$76.3K 4.69% 8
2015
Q2 		$10.2M Sell
57,678
-987
-2% -$177K 5.04% 6
2015
Q1 		$10.1M Buy
58,665
+1,897
+3% +$326K 4.86% 6
2014
Q4 		$9.29M Buy
56,768
+23,503
+71% +$3.9M 4.53% 7
2014
Q3 		$5.34M Buy
33,265
+234
+0.7% +$36K 3.1% 12
2014
Q2 		$4.86M Buy
33,031
+3,241
+11% +$449K 2.88% 17
2014
Q1 		$4.13M Sell
29,790
-84,723
-74% -$12.8M 2.68% 22
2013
Q4 		$14.5M Buy
+114,513
New +$11.8M 7.87% 1

Other funds holding JAZZ

PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Riggs Asset Management's JAZZ Position: Q4 2016 in Review

Riggs Asset Management sold out of Jazz Pharmaceuticals (JAZZ) in Q4 2016, closing a stake of 75 shares — an estimated $9K sold.

Riggs Asset Management first reported a position in JAZZ in Q4 2013 and held it in 12 quarters. The position peaked at $14.5M in Q4 2013. 295 funds tracked by Wall St. Rank hold JAZZ as of Q4 2016.

  • Riggs Asset Management reported no remaining Jazz Pharmaceuticals position as of Q4 2016 after selling out during the quarter.
  • Riggs Asset Management sold 75 Jazz Pharmaceuticals shares in Q4 2016, an estimated $9K.
  • Riggs Asset Management first reported a position in Jazz Pharmaceuticals in Q4 2013 and held it in 12 quarters.
  • Riggs Asset Management's Jazz Pharmaceuticals position peaked at $14.5M in Q4 2013.
  • 295 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q4 2016.

Based on Riggs Asset Management's 13F filing for Q4 2016, filed 26 Jan 2017.